1. Home
  2. AVTX vs INTT Comparison

AVTX vs INTT Comparison

Compare AVTX & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • INTT
  • Stock Information
  • Founded
  • AVTX 2011
  • INTT 1981
  • Country
  • AVTX United States
  • INTT United States
  • Employees
  • AVTX N/A
  • INTT N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • INTT Semiconductors
  • Sector
  • AVTX Health Care
  • INTT Technology
  • Exchange
  • AVTX Nasdaq
  • INTT Nasdaq
  • Market Cap
  • AVTX 57.4M
  • INTT 77.3M
  • IPO Year
  • AVTX 2015
  • INTT 1997
  • Fundamental
  • Price
  • AVTX $4.93
  • INTT $7.43
  • Analyst Decision
  • AVTX Strong Buy
  • INTT Strong Buy
  • Analyst Count
  • AVTX 7
  • INTT 2
  • Target Price
  • AVTX $31.00
  • INTT $12.00
  • AVG Volume (30 Days)
  • AVTX 103.2K
  • INTT 30.2K
  • Earning Date
  • AVTX 08-11-2025
  • INTT 08-01-2025
  • Dividend Yield
  • AVTX N/A
  • INTT N/A
  • EPS Growth
  • AVTX N/A
  • INTT N/A
  • EPS
  • AVTX N/A
  • INTT N/A
  • Revenue
  • AVTX $441,000.00
  • INTT $127,503,000.00
  • Revenue This Year
  • AVTX N/A
  • INTT N/A
  • Revenue Next Year
  • AVTX N/A
  • INTT $10.07
  • P/E Ratio
  • AVTX N/A
  • INTT N/A
  • Revenue Growth
  • AVTX N/A
  • INTT 5.19
  • 52 Week Low
  • AVTX $3.39
  • INTT $5.24
  • 52 Week High
  • AVTX $16.00
  • INTT $11.92
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 54.23
  • INTT 69.96
  • Support Level
  • AVTX $4.50
  • INTT $6.73
  • Resistance Level
  • AVTX $5.02
  • INTT $7.26
  • Average True Range (ATR)
  • AVTX 0.36
  • INTT 0.38
  • MACD
  • AVTX 0.05
  • INTT 0.08
  • Stochastic Oscillator
  • AVTX 72.92
  • INTT 98.10

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.

Share on Social Networks: